Please ensure Javascript is enabled for purposes of website accessibility Best Diet Approach for Long Covid

My Cart


science nutrition blog

science nutrition <strong>blog</strong>

By Steve Blechman


It was reported July 15th, 2022 in Medical “A new USC study finds that 23% of people infected with COVID will become “long haulers” and identifies predictors of who is likely to develop the sometimes-debilitating symptoms that can last for months.”

The new study was published in the journal Scientific Reports on July 8th, 2022. “People who have COVID-19 can experience symptoms for months.” Common symptoms reported were headache, abdominal discomfort and fatigue. Other common symptoms by people experiencing long COVID are muscle pain, shortness of breath and memory loss. The researchers acknowledge, “Long COVID is a major public concern. More knowledge on its prevalence, persistent symptoms and risk factors may help health care professionals allocate resources and services to help long haulers get back to normal lives.”

It was reported in The Wall Street Journal on Monday, July 11, 2022 by David Wainer that “long covid, like other post-viral disorders is characterized by a range of symptoms. For some it causes neurological problems like brain fog, while others it is digestive systems such as diarrhea. Studies also show a small percentage of those infected go on to develop blood clots, stroke, diabetes, and kidney damage. The range of symptoms is so broad partly because long COVID is an umbrella term encompassing different types of complications, including a lingering presence of the virus in the body for a prolonged inflammatory response.”

In a new study published on July 19, 2022 in the journal PLOS Medicine, scientists reported that COVID-19 increases inflammation and may increase the risk in some people of cardiovascular disease (blood clots and irregular heartbeats) and diabetes three months after infection.

It was reported in U.S. News and World Report on May 12th, 2022 that “new evidence suggests that long COVID patients suffer rampant inflammation that wracks the entire body – and that easing inflammation can be key to saving their lives.” This new evidence was published May 12 2022 in the journal Frontiers in Medicine. It has been reported in the scientific literature that “elevated inflammatory mediators – compromising the so-called cytokine storm – induced by the SARS-CoV-2 virus (pathogen) during acute phase could induce a sustained and long-lasting systemic inflammatory response.” (Lancet Respiration Med, April 23, 2022)

Recent research has shown that the cytokine storm is a dangerous hyperimmune reaction with long Covid from the coronavirus in the lungs, in which the immune system overproduces inflammatory cytokines, which can damage lungs and cause inflammation of the air sacs of the lung, which can inhibit oxygen in the body – causing pneumonia and respiratory failure. (eBioMedicine, July 20, 2022) Recent research has shown that the cytokine storm can also cause inflammation and cell damage to the heart, liver, brain, kidneys, intestines, as well as cause abnormal blood clots, which are causing lower body amputations and sudden cardiac thrombosis and death.

In those people infected with the COVID-19 virus, the coronavirus particles enter your body through your nose, mouth or eyes, into your lungs. The immune system recognizes the virus and sends immune-signaling molecules called cytokines such as interleukin-6 (IL-6) and tumor necrosis factor (TNF). Normally these cytokines play a beneficial role by activating our innate immune response and certain white blood cells called macrophages, neutrophils and natural killer cells that destroy and kill certain dangerous pathogens, bacteria and viruses. These white blood cells are like “killer, phagocytic Pac-Men” that release reactive oxygen species (ROS) free radicals and kill these bacteria and viruses. At the same time, these ROS free radical species damage normal tissues and cause inflammation and cell death. So these white blood cells in fact are a two-edged sword – they kill dangerous viruses and bacteria or they can go haywire, causing severe inflammation cell damage and organ failure!

The anti-inflammatory drugs approved for treating rheumatoid arthritis such as tocilizumab (Actemra) has great potential in treating COVID-19 patients with the deadly cytokine storm. Also, the inexpensive generic steroid drug dexamethasone reduces death rates by one-third with the most severe cases of infections. It is a major breakthrough treatment. These anti-inflammatory drugs reduce inflammation and tame down the cytokine storm and hyperactive immune response in some very ill patients. These drugs also have many side effects, but the benefits far outweigh the risks and can potentially save many lives!

Also, as early as 2005 “The FDA warned that taking non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen increase risk of having a heart attack or stroke.” (Sources: Harvard Health Publishing, July 13, 2015) Many people abuse these NSAIDs for pain and inflammation. It’s important to take these drugs under the supervision of a physician and take the lowest effective dose for the lowest length of time.

A Harvard Medical School study including researchers from Greece and Spain reported in the journal Metabolism that the Mediterranean diet is a very promising nutritional approach for COVID-19. The conclusion of the study said that “the Mediterranean diet may represent a potential strategic therapeutic approach to address both short- and long-term conditions associated with COVID-19 infection and severity and improved mortality and the overall well-being of the infected populations”

The Mediterranean diet, an anti-inflammatory diet, has great potential to naturally help tame down the uncontrolled hyperimmune response, which causes the potentially deadly cytokine storm and severe inflammation. The Mediterranean diet is the healthiest diet based on the latest scientific research. A healthy diet and lifestyle changes, such as following the anti-inflammatory Mediterranean diet along with exercise, has been shown to lower the risk of obesity, metabolic syndrome and high-risk ailments such as cardiovascular disease and diabetes. For the past four years, U.S. News and World Report ranked the Mediterranean diet as the best overall diet for healthy eating. The Mediterranean diet was also ranked #1 for the easiest diet to follow; best diet for diabetes; best heart-healthy diet, and best plant-based diet too. The Mediterranean diet is high in fish containing omega-3 fatty acids, in addition to antioxidant-rich vegetables, red wine and berries rich in polyphenols, beans, lentils, nuts, legumes, avocados and extra-virgin olive oil that are rich in healthy monounsaturated polyunsaturated fats and low in saturated fats. A study by Harvard researchers and reported by the American Heart Association (March 5, 2020) and published in the Journal of the American College of Cardiology (March 2020) found that as little as half a tablespoon of olive oil a day was linked to significant decrease in cardiovascular disease. Research has shown that omega-3 fatty acids (primarily EPA and DHA) found in fatty fish such as salmon have potent anti-inflammatory properties and reduced inflammation and protect against heart disease.

Omega-3 fatty acids (EPA and DHA) both lower inflammation. Some research has shown that DHA is a more anti-inflammatory than EPA. These omega-3 fatty acids can lower inflammatory compounds called leukotrienes in the body. These leukotrienes are produced naturally from arachidonic acid, a polyunsaturated fat found in animal fats present in meat, poultry, eggs and cheese. High arachidonic acid levels in the body can increase inflammation and the inflammatory cascade, which can lead to the cytokine storm in susceptible individuals. That’s why it’s very important to limit animal fats and arachidonic acid in the anti-inflammatory Mediterranean diet and eat more omega-3 rich fish such as salmon.

Research has shown that inflammation is a major risk factor for cardiovascular disease. Research has shown that the traditional Mediterranean diet can reduce inflammation and improve cardiovascular health (Nutrients, August 9, 2020). Sixteen years ago the ATTICA Study (J Am Coll Cardiol, July 2004) found that the Mediterranean diet was associated with a 20% lower c-reactive protein (CRP) and 17% lower levels of interleukin-6 (IL-6.) CRP and IL-6 are elevated in systemic inflammation in the body. This was an observational study and demonstrated an association but not proof of cause and effect like a randomized, double-blind clinical trial; also, a similar study a year later called the Nurses’ Cohort in the USA (Am J Clin Nut, July 2005) was associated to a 24% lower c-reactive protein and 16% lower levels of interleukin-6 (IL-6). These very well conducted observational studies were later confirmed by a randomized clinical trial (PREDIMED pilot study). The Mediterranean diet supplemented with extra-virgin olive oil for three months that human adults followed reduced c-reactive protein. The Mediterranean diet, as I mentioned, was supplemented with extra-virgin oil containing monounsaturated fats and polyphenols and lowered low-grade inflammation implicated in the mechanism leading to atherosclerotic disease (Nutr Metab, September 2014). The PREDIMED trial later involving 1,139 high-risk cardiovascular adults further confirmed a dose-dependent anti-inflammatory of the Mediterranean diet rich in polyphenols based on measuring inflammatory biomarkers such as c-reactive protein and interleukin-6 (Br J Clin Pharmaca, January 2017). A later study (CANTOS trial) found that a monoclonal antibody that reduces c-reactive protein and interleukin-6, and inflammation, further confirmed the inflammatory hypothesis in atherosclerosis and cardiovascular disease without lowering blood lipids (N Engel J Med, Jan. 1999, Endocrinol Diabet Nutr, Nov. 2017). The Mediterranean diet containing extra-virgin olive oil, fruits, and red wine is rich in polyphenols with potent anti-inflammatory properties.

The Cleveland Clinic published a scientific review (June 2, 2020, Cleveland Clinic Journal of Medicine) entitled, “What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19?” The review mentioned that zinc, vitamin D, and N-acetylcysteine (NAC) can lower pro-inflammatory cytokines such as interleukin-6 (IL-6), interleukin-1 (IL-1) and tumor necrosis factor (TNF). The authors outline, “the biological plausibility, applicable clinical data and potential role of each of these agents.” The Cleveland Clinic Investigators continued to say that, “several agents intended to supplement dietary intake or indigenous molecules may have a theoretical role in preventing or treating COVID-19.” Based on their scientific review, the authors further acknowledge that “ascorbic acid, zinc, vitamin D, and N-acetylcysteine have biologic plausibility for prevention and treatment of COVID-19 and are candidates for clinical trials evaluating patients with these indications.”†

In conclusion, long Covid affects 23% of positive cases causing symptoms that may last for months! The coronavirus is not just going to disappear. We need to learn to live with the virus. We need to improve our health and lower our risks of getting COVID-19. We already know that people over 65 have higher systemic inflammation. Also, systemic inflammation is higher in overweight and obese people. Also, pre-existing ailments such as metabolic syndrome, hypertension, diabetes, heart and cardiovascular disease increase systemic inflammation and risk of death from COVID-19. A healthy nutritional diet and lifestyle such as the anti-inflammatory Mediterranean diet may help lower inflammation. Clinical trials with the Mediterranean diet need to be done and evaluated in people at high risk of COVID-19. We cannot take our foot off of the pedal! 40% of adults are obese in the United States. Many have metabolic syndrome and systemic inflammation. A simple blood test by your physician can measure your c-reactive protein levels. Eating healthy and improving our metabolic health and exercising more can help control our weight, lower inflammation, and improve our metabolic health.


†These statements have not been evaluated by the Food and Drug Administration. These statements are not intended to diagnose, treat, cure or prevent any disease.


©Published by Advanced Research Media, Inc. 2022

©Reprinted with permission from Advanced Research Media, Inc.




  1. Long COVID affects 23% of positive cases, causing symptoms in 'long haulers' that may last for months. Medical Xpress. July 15, 2022. Leigh Hopper, Univerrsity of Southern California.


  1. Wu, Q., Ailshire, J.A. & Crimmins, E.M. Long COVID and symptom trajectory in a representative sample of Americans in the first year of the pandemic. Sci Rep 12, 11647 (2022).


  1. Florencio LL, Fernández-de-Las-Peñas C. Long COVID: systemic inflammation and obesity as therapeutic targets. Lancet Respir Med. 2022 Apr 22:S2213-2600(22)00159-X. doi: 10.1016/S2213-2600(22)00159-X. Epub ahead of print. PMID: 35472305; PMCID: PMC9034853.


  1. Wall Street Journal. July 11, 2022. For Big Drug Makers, Long Covid is Elusive. David Wainer.


  1. US News & World Report. Long COVID May Be Chronic, Require Anti-Inflammatory Meds: Study. May 12, 2022. Dennis Thompson, HealthDay Reporter.


  1. Negative Association Between Mediterranean Diet Adherence and COVID-19 Cases and Related Deaths in Spain and 23 OECD Countries: An Ecological Study. Michael W. Greene, Alexis P. Roberts, Andrew D. Fruge. Frontiers in Nutrition. Front. Nutr., 05 March 2021.Sec.Nutritional Epidemiology.


  1. Angelidi AM, Kokkinos A, Katechaki E, Ros E, Mantzoros CS. Mediterranean diet as a nutritional approach for COVID-19. Metabolism. 2021 Jan;114:154407. doi: 10.1016/j.metabol.2020.154407. Epub 2020 Oct 17. PMID: 33080270; PMCID: PMC7833284.


  1. Perez-Araluce R, Martínez-González MÁ, Gea A, Carlos S. Components of the Mediterranean Diet and Risk of COVID-19. Front Nutr. 2022 Jan 24;8:805533. doi: 10.3389/fnut.2021.805533. PMID: 35141266; PMCID: PMC8819171.


  1. PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022 Apr 22:S2213-2600(22)00127-8. doi: 10.1016/S2213-2600(22)00127-8. Epub ahead of print. PMID: 35472304; PMCID: PMC9034855.


  1. The Impact of Initial COVID-19 Episode Inflammation Among Adults on Mortality Within 12 Months Post-hospital Discharge. Front. Med., 12 May 2022. Sec.Family Medicine and Primary Care.


  1. Study shows that 8% of athletes have persistent symptoms after contracting COVID-19. Medical Xpress. Karina Toledo, FAPESP. July 8, 2022.


  1. Intermountain Healthcare. People who practice intermittent fasting experience less severe complications from COVID-19, study finds. ScienceDaily, 7 July 2022.


  1. Benjamin D Horne, Heidi T May, Joseph B Muhlestein, Viet T Le, Tami L Bair, Kirk U Knowlton, Jeffrey L Anderson. Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry. BMJ Nutrition, Prevention & Health, 2022; e000462 DOI: 10.1136/bmjnph-2022-000462


  1. University of Portsmouth. Long COVID has a significant impact on UK workforce, study finds. ScienceDaily, 13 July 2022.


  1. Darja Reuschke, Donald Houston. The impact of Long COVID on the UK workforce. Applied Economics Letters, 2022; 1 DOI: 10.1080/13504851.2022.2098239


  1. Munafò, F., Donati, E., Brindani, N. et al. Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase. Sci Rep 12, 10571 (2022).


  1. University of Otago. New research provides insight into Long COVID and ME. ScienceDaily, 12 July 2022.


  1. Warren Tate, Max Walker, Eiren Sweetman, Amber Helliwell, Katie Peppercorn, Christina Edgar, Anna Blair, Aniruddha Chatterjee. Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses. Frontiers in Neurology, 2022; 13 DOI: 10.3389/fneur.2022.877772


  1. Xuhuiqun Zhang, Di Xiao, Gabriela Guzman, Indika Edirisinghe, Britt Burton-Freeman, Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance, The Journal of Nutrition, 2022; nxac126,


  1. Akinyelure OP, Colantonio LD, Chaudhary NS, Jaeger BC, Judd SE, Cushman M, Zakai NA, Kabagambe EK, Howard VJ, Safford MM, Irvin MR. Inflammation biomarkers and incident coronary heart disease: The Reasons for Geographic and Racial Differences in Stroke Study. Am Heart J. 2022 Jul 7:S0002-8703(22)00144-2. doi: 10.1016/j.ahj.2022.07.001. Epub ahead of print. PMID: 35810789.


  1. Martone AM, Tosato M, Ciciarello F, Galluzzo V, Zazzara MB, Pais C, Savera G, Calvani R, Marzetti E, Robles MC, Ramirez M, Landi F; Gemelli Against COVID-19 Post-Acute Care Team. Sarcopenia as potential biological substrate of long COVID-19 syndrome: prevalence, clinical features, and risk factors. J Cachexia Sarcopenia Muscle. 2022 Jun 14. doi: 10.1002/jcsm.12931. Epub ahead of print. PMID: 35698920.


  1. Barrea L, Verde L, Grant WB, Frias-Toral E, Sarno G, Vetrani C, Ceriani F, Garcia-Velasquez E, Contreras-Briceño J, Savastano S, Colao A, Muscogiuri G. Vitamin D: A Role Also in Long COVID-19? Nutrients. 2022 Apr 13;14(8):1625. doi: 10.3390/nu14081625. PMID: 35458189; PMCID: PMC9028162.


  1. Vollbracht C, Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front Pharmacol. 2022 Apr 29;13:899198. doi: 10.3389/fphar.2022.899198. PMID: 35571085; PMCID: PMC9100929.


  1. Kao J, Frankland PW. COVID fog demystified. Cell. 2022 Jul 7;185(14):2391-2393. doi: 10.1016/j.cell.2022.06.020. Epub 2022 Jun 15. PMID: 35768007; PMCID: PMC9197953.


  1. Pedrosa LFC, Barros ANAB, Leite-Lais L. Nutritional risk of vitamin D, vitamin C, zinc, and selenium deficiency on risk and clinical outcomes of COVID-19: A narrative review. Clin Nutr ESPEN. 2022 Feb;47:9-27. doi: 10.1016/j.clnesp.2021.11.003. Epub 2021 Nov 6. PMID: 35063248; PMCID: PMC8571905.


  1. Younesian O, Khodabakhshi B, Abdolahi N, Norouzi A, Behnampour N, Hosseinzadeh S, Alarzi SSH, Joshaghani H. Decreased Serum Selenium Levels of COVID-19 Patients in Comparison with Healthy Individuals. Biol Trace Elem Res. 2022 Apr;200(4):1562-1567. doi: 10.1007/s12011-021-02797-w. Epub 2021 Jul 1. PMID: 34195940; PMCID: PMC8245273.


  1. Maares M, Hackler J, Haupt A, Heller RA, Bachmann M, Diegmann J, Moghaddam A, Schomburg L, Haase H. Free Zinc as a Predictive Marker for COVID-19 Mortality Risk. Nutrients. 2022 Mar 28;14(7):1407. doi: 10.3390/nu14071407. PMID: 35406020; PMCID: PMC9002649.


  1. Mal'tseva VN, Goltyaev MV, Turovsky EA, Varlamova EG. Immunomodulatory and Anti-Inflammatory Properties of Selenium-Containing Agents: Their Role in the Regulation of Defense Mechanisms against COVID-19. Int J Mol Sci. 2022 Feb 21;23(4):2360. doi: 10.3390/ijms23042360. PMID: 35216476; PMCID: PMC8880504.


  1. Majeed M, Nagabhushanam K, Prakasan P, Mundkur L. Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review. Int J Mol Sci. 2022 Apr 27;23(9):4809. doi: 10.3390/ijms23094809. PMID: 35563199; PMCID: PMC9105991.


  1. Chen G, Lu H. Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? Drug Discov Ther. 2022 May 6. doi: 10.5582/ddt.2022.01032. Epub ahead of print. PMID: 35527020.


  1. Alzaabi MM, Hamdy R, Ashmawy NS, Hamoda AM, Alkhayat F, Khademi NN, Al Joud SMA, El-Keblawy AA, Soliman SSM. Flavonoids are promising safe therapy against COVID-19. Phytochem Rev. 2022;21(1):291-312. doi: 10.1007/s11101-021-09759-z. Epub 2021 May 22. PMID: 34054380; PMCID: PMC8139868.


  1. Olive oil may lower heart disease risk. American Heart Association News. March 5, 2020.


  1. Olive Oil Consumption and Cardiovascular Risk in U.S. Adults. Journal of the American College of Cardiology. Marta Guasch-Ferré, Gang Liu, Yanping Li, Laura Sampson, JoAnn E. Manson, Jordi Salas-Salvadó, Miguel A. Martínez-González, Meir J. Stampfer, Walter C. Willett, Qi Sun, Frank B. Hu. Journal of the American College of Cardiology. April 2020.


  1. FDA strengthens warning that NSAIDs increase heart attack and stroke risk. July 13, 2015. Harvard Health Publishing. Harvard Medical School.


  1. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. 16 June 2020. Nature.


  1. Razquin C, Martinez-Gonzalez MA. A Traditional Mediterranean Diet Effectively Reduces Inflammation and Improves Cardiovascular Health. Nutrients. 2019;11(8):1842. Published 2019 Aug 9. doi:10.3390/nu11081842


  1. Ying Chi, Yiyue Ge, Bin Wu, Wenshuai Zhang, Tao Wu, Tian Wen, Jingxian Liu, Xiling Guo, Chao Huang, Yongjun Jiao, Fengcai Zhu, Baoli Zhu, Lunbiao Cui, Serum Cytokine and Chemokine profile in Relation to the Severity of Coronavirus disease 2019 (COVID-19) in China, The Journal of Infectious Diseases, , jiaa363,


  1. Zabetakis, I.; Lordan, R.; Norton, C.; Tsoupras, A. COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients 2020, 12, 1466.


  1. COVID-19 cytokine storm: The anger of inflammation. Mehdi Mahmudpour, Jamshid Roozbeh, Mohsen Keshavarz, Shokrollah Farrokhi, Iraj Nabipour. Cytokine. September 2020


  1. Wang, J, Jiang, M, Chen, X, Montaner, LJ. Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. June 13, 2020; 1-25.


  1. Roy AS, Matson M, Herlekar R. Response to 'Vitamin D concentrations and COVID-19 infection in UK Biobank' [published online ahead of print, 2020 Jun 4]. Diabetes Metab Syndr. 2020;14(5):777. doi:10.1016/j.dsx.2020.05.049


  1. Quesada-Gomez JM, Castillo ME, Bouillon R. Vitamin D Receptor stimulation to reduce Acute Respiratory Distress Syndrome (ARDS) in patients with Coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166 [published online ahead of print, 2020 Jun 11]. J Steroid Biochem Mol Biol. 2020;105719. doi:10.1016/j.jsbmb.2020.105719


  1. Silberstein M. Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? [published online ahead of print, 2020 Apr 23]. Med Hypotheses. 2020;140:109767. doi:10.1016/j.mehy.2020.109767


  1. New Rules for Covid Summer: Be Flexible and Vigilant by Scott Gottleib, Yuval Levin, Monday June 15, 2020


  1. Steroid drug hailed as “breakthrough” in COVID-19 as trial shows it saves lives. June 16, 2020. Kate Kelland, Alistair Smout. Reuters.


  1. What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19? Seth R. Bauer, Aanchal Kapoor, Mary Rath, Suma A. Thomas, Cleveland Clinic Journal of Medicine Jun 2020, DOI: 10.3949/ccjm.87a.ccc046


  1. Risk of COVID‐19 for patients with obesity. Radwan Kassir. April 13, 2020. Obesity Reviews.


  1. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. Mandeep R. Mehra, M.D., Sapan S. Desai, M.D., Ph.D., SreyRam Kuy, M.D., M.H.S., Timothy D. Henry, M.D., and Amit N. Patel, M.D. May 1, 2020. DOI: 10.1056/NEJMoa2007621


  1. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. April 28, 2020. DOI: 10.1056/NEJMc2009787


  1. Fish Consumption in Healthy Adults Is Associated with Decreased Circulating Biomarkers of Endothelial Dysfunction and Inflammation during a 6-Year Follow-Up. Bas C. T. van Bussel, Ronald M. A. Henry, Casper G. Schalkwijk, Isabel Ferreira, Edith J. M. Feskens, Martinette T. Streppel, Yvo M. Smulders, Jos W. R. Twisk, Coen D. A. Stehouwer. The Journal of Nutrition, Volume 141, Issue 9, September 2011, Pages 1719-1725,


  1. Ratih Wirapuspita Wisnuwardani, Stefaan De Henauw, Marika Ferrari, Maria Forsner, Frédéric Gottrand, Inge Huybrechts, Antonios G Kafatos, Mathilde Kersting, Viktoria Knaze, Yannis Manios, Ascensión Marcos, Dénes Molnár, Joseph A Rothwell, Azahara Iris Rupérez, Augustin Scalbert, Kurt Widhalm, Luis A Moreno, Nathalie Michels, Total Polyphenol Intake Is Inversely Associated with a Pro/Anti-Inflammatory Biomarker Ratio in European Adolescents of the HELENA Study, The Journal of Nutrition, nxaa064,


  1. Kate J Claycombe-Larson, Travis Alvine, Dayong Wu, Nishan S Kalupahana, Naima Moustaid-Moussa, James N Roemmich, Nutrients and Immunometabolism: Role of Macrophage NLRP3, The Journal of Nutrition, nxaa085,


  1. Calder, P.C.; Carr, A.C.; Gombart, A.F.; Eggersdorfer, M. Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients 2020, 12, 1181.


  1. Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases. Author links open overlay panel. Richard I.Horowitz. Phyllis R.Freeman. James Bruzzesec. Respiratory Medicine Case Reports. Volume 30, 2020, 101063.


  1. Obesity Exacerbates the Cytokine Storm Elicited by Francisella tularensis Infection of Females and Is Associated with Increased Mortality. Mireya G. Ramos Muniz et al. June 26, 2018. Journal of Bio Med Rsch.


  1. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1286


  1. Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1105


  1. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1017


  1. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1286


  1. Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1105


  1. Genentech Announces FDA Approval of Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumonia. March 23, 2020. AP News Wire


  1. Obesity Exacerbates the Cytokine Storm Elicited by Francisella tularensis Infection of Females and Is Associated with Increased Mortality. Mireya G. Ramos Muniz, Matthew Palfreeman et al. Advances in Emerging and Neglected Infectious Diseases June 26, 2018. BioMed Research International.


  1. Spanish Ketogenic Mediterranean diet: a healthy cardiovascular diet for weight loss. Nutrition Journal, 2008, Volume 7, Number 1, Page 1. Joaquín Pérez-Guisado, Andrés Muñoz-Serrano, Ángeles Alonso-Moraga


  1. Long-term successful weight loss with a combination biphasic ketogenic Mediterranean diet and Mediterranean diet maintenance protocol. Paoli, A., Bianco, A., Grimaldi, K. A., Lodi, A., & Bosco, G. (2013). Nutrients, 5 (12), 5205-17. doi:10.3390/nu5125205


  1. Effect of ketogenic Mediterranean diet with phytoextracts and low carbohydrates/high-protein meals on weight, cardiovascular risk factors, body composition and diet compliance in Italian council employees. Paoli, A., Cenci, L., & Grimaldi, K. A. (2011). Nutrition journal, 10, 112. doi:10.1186/1475-2891-10-112


  1. Mediterranean Diet Reduces Risk of Incident Stroke in a Population With Varying Cardiovascular Disease Risk Profiles. Paterson, K. E., Myint, P. K., Jennings, A., Bain, L., Lentjes, M., Khaw, K. T., & Welch, A. A. (Oct 2018). Stroke, 49 (10), 2415-2420. Advance online publication. doi:10.1161/STROKEAHA.117.020258


  1. Ahmad S, Moorthy MV, Demler OV, et al. Assessment of Risk Factors and Biomarkers Associated With Risk of Cardiovascular Disease Among Women Consuming a Mediterranean Diet. JAMA Netw Open. Dec. 7, 2018;1(8):e185708. doi:10.1001/jamanetworkopen.2018.5708


  1. Marialaura Bonaccio, Augusto Di Castelnuovo, Simona Costanzo, Mariarosaria Persichillo, Amalia De Curtis, Chiara Cerletti, Maria Benedetta Donati, Giovanni de Gaetano, Licia Iacoviello. Interaction between Mediterranean diet and statins on mortality risk in patients with cardiovascular disease: Findings from the Moli-sani Study. International Journal of Cardiology, 2018; DOI: 10.1016/j.ijcard.2018.11.117


  1. Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools: The CENTRAL MRI Randomized Controlled Trial. Yftach Gepner, Ilan Shelef, Dan Schwarzfuchs, Hila Zelicha, Lilac Tene, Anat Yaskolka Meir, Gal Tsaban, Noa Cohen, Nitzan Bril, Michal Rein, Dana Serfaty, Shira Kenigsbuch, Oded Komy, Arik Wolak, Yoash Chassidim, Rachel Golan, Hilla Avni-Hassid, Avital Bilitzky, Benjamin Sarusi, Eyal Goshen, Elad Shemesh, Yaakov Henkin, Michael Stumvoll, Matthias Blüher, Joachim Thiery, Uta Ceglarek, Assaf Rudich, Meir J. Stampfer and Iris Shai. Circulation 2017;CIRCULATION AHA.117.030501, 2017.


  1. Zong, G., Li, Y., Wanders, A.J., Alssema, M., Zock, P.L., Willett, W.C., Hu, F.B., Sun, Q. Intake of individual saturated fatty acids and risk of coronary heart disease in US men and women: two prospective longitudinal cohort studies BMJ. 2016;355:i5796.


  1. Nut intake and 5-year changes in body weight and obesity risk in adults: results from the EPIC-PANACEA study. European Journal of Nutrition, 2017, Page 1 Heinz Freisling, Hwayoung Noh, Nadia Slimani.


  1. Wiley. Fish consumption may prolong life. ScienceDaily, 18 July 2018.


  1. Zhang, P. Zhuang, W. He, J. N. Chen, W. Q. Wang, N. D. Freedman, C. C. Abnet, J. B. Wang, J. J. Jiao. Association of fish and long-chain omega-3 fatty acids intakes with total and cause-specific mortality: prospective analysis of 421 309 individuals. Journal of Internal Medicine, 2018; DOI: 10.1111/joim.12786


  1. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association Frank M. Sacks, MD, FAHA, Chair, Alice H. Lichtenstein, DSc, FAHA, Jason H.Y. Wu, PhD, MSc, Lawrence J. Appel, MD, MPH, FAHA, Mark A. Creager, MD, FAHA, Penny M. Kris-Etherton, PhD, RD, FAHA, Michael Miller, MD, FAHA, Eric B. Rimm, ScD, FAHA, Lawrence L. Rudel, PhD, FAHA, Jennifer G. Robinson, MD, MPH, FAHA, Vice Chair, Neil J. Stone, MD, FAHA, and Linda V. Van Horn, PhD, RD, FAHA, Vice Chair On behalf of the American Heart Association.


  1. Mediterranean Diet Reduces Risk of Incident Stroke in a Population With Varying Cardiovascular Disease Risk Profiles. Paterson, K. E., Myint, P.K., Jennings, A., Bain, L., Lentjes, M., Khaw, K.T., & Welch, A.A. (Oct 2018). Stroke, 49 (10), 2415-2420. Advance online publication. doi:10.1161/STROKEAHA.117.020258


  1. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association Frank M. Sacks, MD, FAHA, Chair, Alice H. Lichtenstein, DSc, FAHA, Jason H.Y. Wu, PhD, MSc, Lawrence J. Appel, MD, MPH, FAHA, Mark A. Creager, MD, FAHA, Penny M. Kris-Etherton, PhD, RD, FAHA, Michael Miller, MD, FAHA, Eric B. Rimm, ScD, FAHA, Lawrence L. Rudel, PhD, FAHA, Jennifer G. Robinson, MD, MPH, FAHA, Vice Chair, Neil J. Stone, MD, FAHA, and Linda V. Van Horn, PhD, RD, FAHA, Vice Chair On behalf of the American Heart Association


  1. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The Attica study. Journal of the American College of Cardiology. 2004.


  1. Teresa T Fung, Marjorie L McCullough, PK Newby, JoAnn E Manson, James B Meigs, Nader Rifai, Walter C Willett, Frank B Hu, Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction, The American Journal of Clinical Nutrition, Volume 82, Issue 1, July 2005, Pages 163–173,


  1. Estruch R, Martínez-González MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial [published correction appears in Ann Intern Med. 2018 Aug 21;169(4):270-271]. Ann Intern Med. 2006;145(1):1-11. doi:10.7326/0003-4819-145-1-200607040-00004


  1. Schwingshackl L, Christoph M, Hoffmann G. Effects of Olive Oil on Markers of Inflammation and Endothelial Function-A Systematic Review and Meta-Analysis. Nutrients. 2015;7(9):7651-7675. Published 2015 Sep 11. doi:10.3390/nu7095356


  1. Medina-Remón A, Casas R, Tressserra-Rimbau A, et al. Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial. Br J Clin Pharmacol. 2017;83(1):114-128. doi:10.1111/bcp.12986


  1. Sureda A, Bibiloni MDM, Julibert A, et al. Adherence to the Mediterranean Diet and Inflammatory Markers. Nutrients. 2018;10(1):62. Published 2018 Jan 10. doi:10.3390/nu10010062


  1. Ruiz-Canela M, Estruch R, Corella D, Salas-Salvadó J, Martínez-González MA. Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial [published correction appears in JAMA. 2018 Dec 4;320(21):2272]. JAMA. 2014;311(4):415-417. doi:10.1001/jama.2013.280618


  1. Martínez-González MA, Salas-Salvadó J, Estruch R, et al. Benefits of the Mediterranean Diet: Insights From the PREDIMED Study. Prog Cardiovasc Dis. 2015;58(1):50-60. doi:10.1016/j.pcad.2015.04.003


  1. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. Ramón Estruch, Emilio Ros, Jordi Salas-Salvadó, et al. The New England Journal of Medicine. Massachusetts Medical Society. Apr 4, 2013


  1. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. Paul M Ridker, Brendan M. Everett, Tom Thuren. The New England Journal of Medicine Date: Sep 21, 2017


  1. Atherosclerosis - An Inflammatory Disease. Russell Ross. January 14, 1999


  1. Ruiz-Canela M, Martínez-González MA. Blocking inflammation: a new arsenal against atherosclerosis. Bloqueo de la inflamación: nuevo arsenal contra la arteriosclerosis. Endocrinol Diabetes Nutr. 2017;64(10):515-516. doi:10.1016/j.endinu.2017.10.003


  1. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. Emma Rezel-Potts, Abdel Douiri, Xiaohui Sun, Phillip J. Chowienczyk, Ajay M. Shah, Martin C. Gulliford. Plos Medicine, published July 19, 2022


  1. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis. Saptarshi Sinha, Vanessa Castillo, Celia R. Espinoza, Courtney Tindle, Ayden G. Fonseca, Jennifer M. Dan, et al. eBioMedicine, published July 20, 2022. DOI: